@szcyxzh First off, I am not this X poster. I will say that this X poster provides insightful due diligence and has made fairly accurate predictions in the biotech world. Two examples being the acquisition of $INZY (another radiopharma biotech) and the clinical readout of $PYXS.
You do you, but proper due diligence shouldn’t be derided unless it’s not factual. I verified this post and everything is factual when you cross check it with EDGAR filings and LinkedIn.
There is a difference between a baseless pumper and a thoughtful investor.
$BCAB very nice resilience and strength today. That's how you know the deal is legit. Remember $INZY trading ahead of its buyout? Very similar trading pattern/price action.
$IXHL $TELO Bios that drop on good news? Finding the dip is the art. ixhl is really crazy, though; I'll wait until tomorrow. However, I have a deja vu from May 8th, when I missed the tsunami at $INZY after riding all those waves. No FOMO; if you miss the wave, wait patiently for the next one.
$INZY Outstanding article that hits the mark on INZY's current state. So if you want to refresh your INZY insights or learn about INZY from scratch, this is a must read. https://beyondspx.com/article/inozyme-pharma-high-stakes-pivot-towards-rare-disease-approval-in-enpp1-deficiency-inzy
$INZY NASDAQ Equity Corporate Actions Alert # 2025 - 335
Information Regarding the Tender Offer of Inozyme Pharma, Inc. (INZY)
https://www.nasdaqtrader.com/TraderNews.aspx?id=ECA2025-335
The tender offer by BioMarin Pharmaceutical Inc. ($BMRN) to acquire all of the outstanding common stock of Inozyme Pharma, Inc. (INZY) is scheduled to expire one minute after 11:59 p.m. ET, on June 30, 2025, unless extended or terminated. The subsequent merger is tentatively scheduled to close prior to the market open on July 1, 2025. In anticipation of the closing, the stock will be halted immediately following the after-hours session at or around 7:50 p.m. on June 30, 2025. If the merger closes as planned, the stock will remain halted on the day of closing (July 1st) and will be suspended effective July 2, 2025.
Merger consideration is $4 per share.
$INZY did anyone receive an email for voluntary sale of your shares? I got a message from Tobinhood with a pdf attached which was signed by both Innozyme and Biomarin representatives.
I thought that the money will get deposited in my account automatically after the merger is completed.
